XML 41 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segmentation of key figures - Net sales by segment and Consolidated income statements (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Disclosure of operating segments [line items]        
Net sales to third parties $ 2,482 $ 2,402 $ 4,926 $ 4,735
Other revenues 14 20 29 39
Net sales and other revenues 2,496 2,422 4,955 4,774
Total segment contribution 583 581 1,227 1,161
Amortization of intangible assets (184) (187) (367) (377)
Impairment charges on intangible assets (9) 0 (9) 0
General & administration (corporate) (73) (74) (148) (142)
Transformation costs 0 (26) 0 (52)
Integration related costs 0 (8) 0 (14)
Other 1 (16) (17) (38)
Operating income 318 270 686 538
Interest expense (50) (48) (95) (95)
Other financial income & expense 12 (9) 24 (17)
Income before taxes 280 213 615 426
Surgical        
Disclosure of operating segments [line items]        
Net sales to third parties 1,423 1,382 2,761 2,686
Total segment contribution 403 407 789 788
Surgical | Implantables        
Disclosure of operating segments [line items]        
Net sales to third parties 464 437 897 864
Surgical | Consumables        
Disclosure of operating segments [line items]        
Net sales to third parties 736 714 1,422 1,370
Surgical | Equipment/other        
Disclosure of operating segments [line items]        
Net sales to third parties 223 231 442 452
Vision Care        
Disclosure of operating segments [line items]        
Net sales to third parties 1,059 1,020 2,165 2,049
Total segment contribution 180 174 438 373
Vision Care | Contact lenses        
Disclosure of operating segments [line items]        
Net sales to third parties 636 594 1,307 1,209
Vision Care | Ocular health        
Disclosure of operating segments [line items]        
Net sales to third parties $ 423 $ 426 $ 858 $ 840